Stay updated with breaking news from Nasdaq Grcl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gracell Biotechnologies (NASDAQ:GRCL – Get Rating)‘s stock had its “overweight” rating reiterated by stock analysts at Wells Fargo & Company in a research note issued on Thursday, Stock Target Advisor reports. GRCL has been the subject of several other research reports. Piper Sandler decreased their target price on Gracell Biotechnologies from $25.00 to $10.00 in […]
Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) saw a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 802,000 shares, an increase of 38.6% from the May 15th total of 578,600 shares. Approximately 1.4% of the company’s shares are sold short. Based on an average […]
Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Rating) – Equities research analysts at Cantor Fitzgerald issued their FY2023 earnings per share (EPS) estimates for Gracell Biotechnologies in a research note issued on Monday, June 6th. Cantor Fitzgerald analyst L. Chen expects that the company will earn ($0.28) per share for the year. Cantor Fitzgerald currently has […]
Cantor Fitzgerald began coverage on shares of Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) in a research note issued to investors on Wednesday, The Fly reports. The firm issued an overweight rating on the stock. A number of other equities analysts also recently commented on the stock. BTIG Research started coverage on shares of Gracell Biotechnologies […]
Stock analysts at Cantor Fitzgerald started coverage on shares of Gracell Biotechnologies (NASDAQ:GRCL – Get Rating) in a research note issued on Wednesday, The Fly reports. The brokerage set an “overweight” rating on the stock. Several other equities research analysts also recently weighed in on the stock. Zacks Investment Research downgraded shares of Gracell Biotechnologies […]